Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004569 · ClinicalTrials.gov registry record · NA
Incorporating Flow Limitation Into the Diagnosis and Quantification of Sleep Disordered Breathing
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00004569: Completed NA study, sponsored by National Center for Research Resources (NCRR).
NCT00004569 is a NA study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004569, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The diagnosis and treatment of sleep disordered breathing have come to the forefront of clinical medicine following recognition of the high prevalence and associated morbidity of sleep apnea. The effects on quality of life as well as societal costs have been well documented. The NYU Sleep Research Laboratory has spent the last several years working on the problem of improving the diagnosis of mild sleep disordered breathing which manifests as the upper airway resistance syndrome. Our approach has been to develop a non-invasive technique to detect increased upper airway resistance directly from analysis of the airflow signal. A characteristic intermittent change of the inspiratory flow contour, which is indicative of the occurrence of flow limitation, correlates well with increased airway resistance. Currently all respiratory events are identified manually and totaled. This is time consuming and subject to variability. The objective of the present project is to improve upon the manual approach by implementing an artificially intelligent system for the identification and quantification of sleep disordered breathing based solely on non-invasive cardiopulmonary signals collected during a routine sleep study. The utility of other reported indices of sleep disordered breathing obtained during a sleep study will be evaluated. Successful development of an automated system that can identify and classify upper airway resistance events will simplify, standardize and improve the diagnosis of sleep disordered breathing, and greatly facilitate research and clinical work in this area. Using a physiological based determination of disease should allow better assessment of treatment responses in mild disease.
Interventions
- PROCEDURE Non-invasive technique to diagnose and quantitate sleep-disordered breathing
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00004569 record still lists
NCT00004569 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive technique to diagnose and quantitate sleep-disordered breathing is the first listed.
NCT00004569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004569 about?
NCT00004569 is a clinical study titled "Incorporating Flow Limitation Into the Diagnosis and Quantification of Sleep Disordered Breathing". The diagnosis and treatment of sleep disordered breathing have come to the forefront of clinical medicine following recognition of the high prevalence and associated morbidity of sleep apnea. The effects on quality of life as well as societal costs have been well documented. The NYU Sleep Research L...
What is the current status of trial NCT00004569?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00004569?
The interventions under investigation include: Non-invasive technique to diagnose and quantitate sleep-disordered breathing (PROCEDURE).
Who is sponsoring clinical trial NCT00004569?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.